Your session is about to expire
← Back to Search
Behavioral Intervention
Health Education for COVID-19 Prevention in Early Learning
N/A
Recruiting
Led By Linda Ko, PhD, MPH
Research Sponsored by University of Washington
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be younger than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up up to nine months
Awards & highlights
Study Summary
This trial looks at how comic books & videos affect COVID-19 preventive behaviors in students & parents ages 3-5.
Who is the study for?
This trial is for parents with children aged 3-5 enrolled in the Early Learning Program in Yakima School District. Parents must have a mailing or email address, speak English or Spanish, and be able to give informed consent.Check my eligibility
What is being tested?
The study tests the impact of health education through comic books and videos on COVID-19 preventive behaviors among young students and their parents.See study design
What are the potential side effects?
Since this trial involves educational materials rather than medical interventions, there are no direct physical side effects expected from participation.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ up to nine months
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~up to nine months
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
School absenteeism
Trial Design
1Treatment groups
Experimental Treatment
Group I: InterventionExperimental Treatment1 Intervention
The students in this arm will receive comic books and their parents videos on the benefits of preventive measures of COVID-19
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Health Education
2014
Completed Phase 3
~4010
Find a Location
Who is running the clinical trial?
University of WashingtonLead Sponsor
1,749 Previous Clinical Trials
1,838,594 Total Patients Enrolled
1 Trials studying Absenteeism
900 Patients Enrolled for Absenteeism
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)NIH
1,977 Previous Clinical Trials
2,680,747 Total Patients Enrolled
1 Trials studying Absenteeism
900 Patients Enrolled for Absenteeism
Linda Ko, PhD, MPHPrincipal InvestigatorUniversity of Washington
1 Previous Clinical Trials
900 Total Patients Enrolled
1 Trials studying Absenteeism
900 Patients Enrolled for Absenteeism
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- I speak English or Spanish.
Research Study Groups:
This trial has the following groups:- Group 1: Intervention
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Other Trials to Consider
Popular Categories
Share this study with friends
Copy Link
Messenger